The Prime Minister will detail his winter strategy this afternoon, with a proposal to deploy a major testing scheme in an attempt to winner over rebels on the Conservative backbenches.
It comes as data from
However shares in Swedish-British pharmaceutical firm AstraZeneca fell 1.1 per cent, defying expectations for a bounce and underperforming the wider market.
PAST WEEK: The FTSE 100 indxt has had a topsy-turvey past week before rising this morning
PAST MONTH: The FTSE 100 has been rising this month, helped by vaccine breakthroughs
PAST YEAR: The FTSE 100 has recovered much of its losses since the start of the pandemic
Today, Mr Johnson is set to tell MPs that non-essential shops can open in all three tiers after the current restrictions expire on December 2, in a boost for retailers.
The PM will set out plans to allow a small number of households across the UK to mix over a limited number of days at Christmas, but is not expected to give specifics.
Appearing virtually in the Commons from quarantine, Mr Johnson will reveal major rapid testing programmes for all areas forced into the highest tier of restrictions.
He will also set out a trial of the repeat testing of close contacts of individuals who test positive for Covid-19 to prevent them from having to isolate.
More areas are expected to enter the higher end of the tiered-system next month, which will be strengthened to safeguard the gains made in the four-week lockdown.
A South Korean dealer works at Hana Bank in Seoul today. Asian markets mostly rose overnight
Ministers will on Thursday set out what tier each area will enter, while one easing expected is to the 10pm curfew rule for pubs and restaurants.
Overnight, Asian markets mostly rose but investor sentiment is divided between optimism over vaccine developments and concern about surging virus cases.
In the US, a lack of movement in stimulus talks on Capitol Hill and a spat between the White House and Federal Reserve on cash for emergency lending tempered moods.
Hopes that the world can begin to return to some form of normal in the new year have been rising this month after top pharma giants announced vaccine trial results.